ESCMID eLibrary

Search results
Icon explanation








-
384266
Pro
14 April 2019
Session: Pro/con: optimised dosing according to PK/PD principles in patients - does it improve the efficacy of antibiotics?
-
L0031
The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: The SMARRT Study
13 April 2019
Session: Other issues and diverse latebreaker aspects
-
384216
How to optimise antibiotic administration in critically ill patients: from PK/PD to TDM
13 April 2019
Session: Applying pharmacokinetic/pharmacodynamic principles in critically-ill patients
-
P2205
Ex vivo characterisation of effects of renal replacement therapy modalities and settings on pharmacokinetics of meropenem-vaborbactam
24 April 2018
Session: Clinical pharmacokinetics
-
S1062
Do we need beta-lactam TDM or can we just use prolonged infusions?
24 April 2018
Session: Individualized antimicrobial therapy – is it worth it?
-
S0207
Where is the limit in terms of side effects with higher dosing, and can toxicodynamics help?
21 April 2018
Session: Challenging breakpoints with supranormal dosing
-
EW0027
TDM of all drugs for all patients?
22 April 2017
Session: The critically ill patient - news and controversies
-
P1258
Comparative effect of equal dose of continuous veno-venous haemofiltration and continuous veno-venous haemodiafiltration on ciprofloxacin population pharmacokinetics in septic patients
11 April 2016
Session: PK/PD of agents against Gram-negatives
-
EV0653
What is the effect of obesity on the population pharmacokinetics of meropenem in critically ill patients?
09 April 2016
Session: Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring
-
P1134
The comparative effects of continuous venovenous haemofiltration vs continuous venovenous haemodiafiltration on the pharmacokinetics of linezolid in critically ill patients
27 April 2015
Session: Pharmacokinetics in various patient groups
Search narrowed by
-
Topics
-
Type of material
-
Time period